ResearcherFred Hutch Cancer CenterNo recent work listed
Saı̈d M. Sebti
Matched on ORCID iD 0000-0001-5163-1038; OpenAlex author ID A5103060677. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2011: 1 paper · 2012: none · 2013: 4 papers · 2014: none · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 10
- Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. Last author DOI 10.1158/1078-0432.ccr-20-4781↗
- Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs. Co-author DOI 10.1186/s12935-019-0876-0↗
- δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis. Co-author DOI 10.18632/oncotarget.15767↗
- EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.jnutbio.2015.02.008↗
- Triciribine Phosphate Monohydrate, an AKT Inhibitor, Enhances Gemcitabine Activity in Pancreatic Cancer Cells. Co-author PMID 26254348↗
- Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabine sensitivity. Co-author DOI 10.1158/1535-7163.mct-12-0719↗
- Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer. Co-author DOI 10.1158/1940-6207.capr-13-0157↗
- Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism. Co-author DOI 10.1371/journal.pone.0052526↗
- Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.2174/1871520611313040009↗
- Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-11-0424↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazim M. Husain · 8 shared papers, 2011–2021 · strength 0.51
- Paper Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-4781↗
- Paper Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated… DOI 10.1186/s12935-019-0876-0↗
- Paper δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer m… DOI 10.18632/oncotarget.15767↗
- Mokenge Peter Malafa · 8 shared papers, 2011–2021 · strength 0.51
- Paper Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-4781↗
- Paper Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated… DOI 10.1186/s12935-019-0876-0↗
- Paper δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer m… DOI 10.18632/oncotarget.15767↗
- Jose Gilberto Trevino · 3 shared papers, 2013–2021 · strength 0.23
- Paper Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-4781↗
- Paper δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer m… DOI 10.18632/oncotarget.15767↗
- Paper Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabi… DOI 10.1158/1535-7163.mct-12-0719↗
- Barbara Ann Centeno · 4 shared papers, 2013–2017 · strength 0.21
- Paper δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer m… DOI 10.18632/oncotarget.15767↗
- Paper EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells. DOI 10.1016/j.jnutbio.2015.02.008↗
- Paper Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model… DOI 10.1158/1940-6207.capr-13-0157↗
- Domenico Coppola · 3 shared papers, 2013–2019 · strength 0.21
- Paper Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated… DOI 10.1186/s12935-019-0876-0↗
- Paper δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer m… DOI 10.18632/oncotarget.15767↗
- Paper Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent… DOI 10.1371/journal.pone.0052526↗
- Rony A. Francois · 3 shared papers, 2011–2019 · strength 0.16
- Paper Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated… DOI 10.1186/s12935-019-0876-0↗
- Paper Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent… DOI 10.1371/journal.pone.0052526↗
- Paper Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in … DOI 10.1158/1535-7163.mct-11-0424↗
- Patrick W. Underwood · 1 shared paper, 2021 · strength 0.11
- Aslamuzzaman Kazi · 1 shared paper, 2021 · strength 0.11
- Jason B. Fleming · 1 shared paper, 2021 · strength 0.11
- Terence Marques Williams · 1 shared paper, 2021 · strength 0.11
- Surinder K. Batra · 1 shared paper, 2019 · strength 0.09
- Richard D. Kim · 1 shared paper, 2015 · strength 0.06
- Chen Wang · 1 shared paper, 2015 · strength 0.05
- Sunil R. Hingorani · 1 shared paper, 2013 · strength 0.04
- Elena Kurenova · 1 shared paper, 2013 · strength 0.04
- Deniz A. Uçar · 1 shared paper, 2013 · strength 0.04
- Steven N. Hochwald · 1 shared paper, 2013 · strength 0.04
- Jianliang Zhang · 1 shared paper, 2013 · strength 0.04
- Srikumar Chellappan · 1 shared paper, 2013 · strength 0.03
- Dung‐Tsa Chen · 1 shared paper, 2013 · strength 0.03
- José M. Pimiento · 1 shared paper, 2013 · strength 0.03
- Pamela Joy Hodul · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.